ClinicalTrials.gg
Not yet recruitingNCT07885111Updated Oct 26, 2026

Effects of Trendelenburg Position and Pneumoperitoneum on Mechanical Power and Respiratory Mechanics During V-NOTES Surgery

An observational study in Vnotes and Respiratory Mechanics, sponsored by Burcu Ayvazoğlu. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Burcu Ayvazoğlu · Observational

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
14
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this observational study is to evaluate the effects of Trendelenburg positioning and pneumoperitoneum on mechanical power and respiratory mechanics in adult women undergoing vaginal natural orifice transluminal endoscopic surgery (vNOTES) for bilateral tubal ligation.

The main questions this study aims to answer are:

  • Does Trendelenburg positioning and pneumoperitoneum increase mechanical power during vNOTES surgery?
  • How do Trendelenburg positioning and pneumoperitoneum affect respiratory mechanics, including driving pressure, lung compliance, and airway pressures?

Participants who are already scheduled to undergo vNOTES bilateral tubal ligation as part of their routine medical care will receive standard general anesthesia and mechanical ventilation. Researchers will record mechanical power and respiratory parameters at six predefined time points during surgery, before and after the application of pneumoperitoneum and Trendelenburg positioning.

A total of 14 adult women will be included. No additional experimental treatment or intervention will be performed as part of the study.

02

Conditions studied

  • Vnotes
  • Respiratory Mechanics
03

In context

Lead sponsor

Burcu Ayvazoğlu is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of 14 adult female patients aged 18 years or older who are scheduled to undergo elective bilateral tubal ligation using the vaginal natural orifice transluminal endoscopic surgery (vNOTES) technique at Yahyali State Hospital, Kayseri, Türkiye.

Eligible participants will have an American Society of Anesthesiologists (ASA) physical status of I-III and will undergo general anesthesia with endotracheal intubation and controlled mechanical ventilation.

Participants will be recruited prospectively from patients scheduled for elective vNOTES surgery. All patients will receive standard surgical and anesthetic care without any study-specific intervention.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 18 years or older.
  • Scheduled for elective bilateral tubal ligation using the vaginal natural orifice transluminal endoscopic surgery (vNOTES) technique at Yahyali State Hospital.
  • Requesting permanent and considered surgically eligible for bilateral tubal ligation.
  • (ASA) physical status I, II, or III.
  • Scheduled to undergo general anesthesia with endotracheal intubation and controlled mechanical ventilation.
  • Eligible for the standardized anesthesia and mechanical ventilation protocol.
  • No clinical condition preventing reliable intraoperative recording of ventilation parameters and respiratory mechanics.
  • Willing to participate in the study and undergo the planned intraoperative measurements.
  • Able to provide written .

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years.
  • Emergency surgery.
  • Surgery performed using a technique other than vNOTES or conversion to conventional laparoscopy or open surgery.
  • IV or higher.
  • Severe chronic pulmonary disease, including severe , severe asthma, or interstitial lung disease.
  • Uncontrolled cardiovascular disease or advanced heart failure.
  • (BMI) ≥35 kg/m².
  • Pregnancy or suspected pregnancy.
  • Chest wall deformity or neuromuscular disease that may affect mechanical ventilation parameters.
  • Missing or unreliable intraoperative measurements.
  • Refusal to participate or failure to provide written .
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
14 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients Undergoing vNOTES Surgery

    This cohort will include 14 adult female patients undergoing elective bilateral tubal ligation using the vaginal natural orifice transluminal endoscopic surgery (vNOTES) technique under general anesthesia with controlled mechanical ventilation. All participants will receive standard surgical and anesthetic care. Trendelenburg positioning and pneumoperitoneum will be performed as part of the routine surgical procedure. Mechanical power and respiratory mechanics parameters will be recorded at six predefined intraoperative time points to evaluate changes associated with Trendelenburg positioning and pneumoperitoneum. No additional experimental intervention or modification of routine clinical care will be performed.

06

What researchers measure

Primary outcomes

  1. Changes in Intraoperative Mechanical Power During vNOTES Surgery

    Mechanical power (J/min) will be calculated using recorded mechanical ventilation parameters. Changes in mechanical power associated with pneumoperitoneum and Trendelenburg positioning will be evaluated at six predefined intraoperative time points (T0-T5). Kopyala

    Time frame: Intraoperatively, from immediately after endotracheal intubation to the end of surgery, at six predefined time points (T0-T5).

Secondary outcomes

  1. Changes in Intraoperative Driving Pressure

    Description: Driving pressure (cmH₂O) will be calculated as plateau pressure minus positive end-expiratory pressure (Pplat - PEEP).

    Time frame: Intraoperatively, from immediately after endotracheal intubation to the end of surgery, at six predefined time points (T0-T5).

  2. Changes in Static Respiratory System Compliance

    Static respiratory system compliance (mL/cmH₂O) will be calculated using tidal volume and driving pressure (VT/\[Pplat - PEEP\]).

    Time frame: Intraoperatively, from immediately after endotracheal intubation to the end of surgery, at six predefined time points (T0-T5).

  3. Changes in Dynamic Respiratory System Compliance

    Dynamic respiratory system compliance (mL/cmH₂O) will be calculated using tidal volume and the difference between peak airway pressure and PEEP (VT/\[Ppeak - PEEP\]).

    Time frame: Intraoperatively, from immediately after endotracheal intubation to the end of surgery, at six predefined time points (T0-T5).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 2 updates
  1. Oct 26, 2026
    Minor edits only
    + 2 other changes: conditions and criteria formatting
  2. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07885111
Lead sponsor
Burcu Ayvazoğlu
Responsible party
Burcu Ayvazoğlu (Anesthesiology and Reanimation Specialist, Yahyali State Hospital) — Sponsor-investigator
First posted
Oct 21, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion